More Americans are expected to take the drugs as a pill rather than as a shot it is cheaper and many people don't want to ...

Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss the approval of a GLP-1 pill for weight ...

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk's highly anticipated oral GLP-1 drug – with a starting dose ...

Appetite-suppressing GLP-1 tablets become accessible in January, and manufacturers and fast-food eateries may be pushed to alter more of their goods.

On Monday, the Food and Drug Administration approved a pill version of Wegovy, Novo Nordisk’s wildly popular weight loss drug ...

Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, ...

Novo Nordisk shares surged nearly 9% in a single session after a key regulatory development in the US. The move signals a ...

A new FDA-approved weight-loss pill offers an alternative for patients who prefer not to use injectable medications.

The U.S. Food and Drug Administration has approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug, ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

Packaged food makers and fast-food chains are bracing for change as GLP-1 pills become available, following FDA approval of Novo Nordisk's Wegovy. The pills, expected to be cheaper than injections, ...

The first GLP-1 pill specifically for obesity, also branded as Wegovy, is a 25-mg oral formulation of semaglutide, the active ingredient in the blockbuster injectable version ...